INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Park, Jin Young
Abrégé
The present invention relates to an apparatus and method for automatically managing a medical procedure for an outpatient and, more particularly, the apparatus comprising a communication interface, a memory, and a processor operably connected to the communication interface and the memory, wherein the processor is configured to: when it is detected that a patient has entered a preset area, confirm the arrival of the patient and add the patient to a list; when the patient is within a predetermined time from a predicted medical treatment time or when the patient's position in a medical treatment order falls within a predetermined range, obtain the location of the patient's terminal; when the obtained location of the patient's terminal is outside a predetermined radius, request standby for medical treatment; and when it is detected that the patient's turn in the medical treatment order has come and the patient has entered an examination room, request medical staff to perform an identity verification procedure.
G16H 40/20 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour la gestion ou l’administration de ressources ou d’établissements de soins de santé, p. ex. pour la gestion du personnel hospitalier ou de salles d’opération
H04W 4/02 - Services utilisant des informations de localisation
H04W 4/80 - Services utilisant la communication de courte portée, p. ex. la communication en champ proche, l'identification par radiofréquence ou la communication à faible consommation d’énergie
G06K 19/06 - Supports d'enregistrement pour utilisation avec des machines et avec au moins une partie prévue pour supporter des marques numériques caractérisés par le genre de marque numérique, p. ex. forme, nature, code
G06Q 20/14 - Architectures de paiement spécialement adaptées aux systèmes de facturation
2.
DEVICE AND METHOD FOR PREDICTING VISCOSITY BY USING ARTIFICIAL INTELLIGENCE IN VISCOSITY PREDICTION SYSTEM
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Lee, Joon Sang
Lee, Hyeong Jun
Abrégé
An embodiment of the present invention provides a device and a method for predicting viscosity by using artificial intelligence in a viscosity prediction system in order to increase accuracy and convenience for viscosity measurement. A system according to an embodiment of the present invention includes: a communication unit for receiving PPG data of a user from a wearable device; a memory; and a control unit for generating a PPG segment by preprocessing the PPG data, predicting at least one parameter of a viscosity model by reflecting the PPG segment to a pre-trained artificial intelligence model, determining the viscosity of the user by using the predicted parameter, and storing the determined viscosity in the memory.
G16H 50/50 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour la simulation ou la modélisation des troubles médicaux
G16H 50/70 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour extraire des données médicales, p. ex. pour analyser les cas antérieurs d’autres patients
G16H 10/60 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données spécifiques de patients, p. ex. pour des dossiers électroniques de patients
A61B 5/024 - Mesure du pouls ou des pulsations cardiaques
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Song, Si Young
Lee, Hee Seung
Jo, Jung Hyun
Park, Soobeen
Abrégé
The present invention relates to a multi-biomarker for diagnosing biliary tract cancer and a use thereof, and, more specifically, to: a composition for diagnosing biliary tract cancer, a kit and a method for diagnosing biliary tract cancer, which comprise an agent capable of measuring the levels of TAGLN2 and CA19-9 proteins or the expression levels of genes encoding same; a pharmaceutical composition for preventing or treating biliary tract cancer, comprising a TAGLN2 inhibitor and a CA19-9 inhibitor; and a method for preventing or treating biliary tract cancer. The biomarker TAGLN2 according to the present invention enables biliary tract cancer to be diagnosed with high specificity and sensitivity, and enables biliary tract cancer to be diagnosed with increased accuracy when combined with CA19-9. Furthermore, TAGLN2 expression in the stroma can predict the prognosis of biliary tract cancer patients.
C12Q 1/6886 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour les maladies provoquées par des altérations du matériel génétique pour le cancer
G01N 33/574 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour le cancer
G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides
G01N 33/53 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Shin, Dong Jun
Lee, Dong Un
Abrégé
An embodiment provides an industrial muscle-strength assistive robot, including: a wearing part; a pair of arm muscle-strength assistive parts connected to the upper body wearing member so as to be adjacent to the shoulders of the user and movable along an upper part of the upper body wearing member; a wire part connecting the pair of arm wearing members and the pair of arm muscle-strength assistive parts; a fixing part coupled to the upper body wearing member so as to be positioned at a bottom part of the pair of arm muscle-strength assistive parts; an auxiliary muscle strength conversion part coupled to the upper body wearing member so as to be positioned at a bottom part of the fixing part and selectively assisting one of waist muscle strength and arm muscle strength of the user; and a string twist driving part coupled to the waist wearing member.
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Kim, Seong Bo
Woo, Hye Won
Son, Yu Jin
Lee, Soo Min
Park, Hyo Kyung
Chun, Jeong Hye
Abrégé
sodCorynebacterium ammoniagenesCorynebacterium ammoniagenes, which enables regulation of gene expression and exhibits significantly stronger activity compared to conventionally used promoters, was developed, promoter variants having various strengths were identified from the developed promoter, and by using the identified improved promoters, two enzymes capable of converting a common sugar into a rare sugar were highly expressed in a single vector system, thereby enabling production of a rare sugar via a one-pot reaction. Accordingly, the promoters can be utilized for the production of a target protein or a rare sugar.
C12N 15/77 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes procaryotes autres que E. coli, p. ex. Lactobacillus, Micromonospora pour CorynebacteriumVecteurs ou systèmes d'expression spécialement adaptés aux hôtes procaryotes autres que E. coli, p. ex. Lactobacillus, Micromonospora pour Brevibacterium
C12N 15/67 - Méthodes générales pour favoriser l'expression
6.
MAXINE NANOSHEET HYBRID COMPOSITE, MANUFACTURING METHOD THEREOF, AND ELECTROCHEMICAL CATALYST INCLUDING SAME
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Hwang, Seong Ju
Sun, Yiyang
Jin, Xiaoyan
Abrégé
An embodiment may provide a metal-positive ion-MXene nanosheet hybrid composite. According to the embodiment, by providing a hybrid composite composed of metal particles/positive ions/MXene nanosheets, there is a feature that may provide a hydrogen evolution reaction catalyst having excellent electrochemical performance with a high current value and low overvoltage.
C25B 11/091 - Électrodes comportant des électro-catalyseurs sur un substrat ou un support caractérisées par le matériau électro-catalytique formé d’au moins un élément catalytique et d’au moins un composé catalytiqueÉlectrodes comportant des électro-catalyseurs sur un substrat ou un support caractérisées par le matériau électro-catalytique formé de plusieurs éléments catalytiques ou composés catalytiques
C25B 1/04 - Hydrogène ou oxygène par électrolyse de l'eau
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Yoon, Duk Yong
Seo, Ji Hoon
Park, Chan Min
Han, Chang Ho
Abrégé
According to this specification, a method for providing information on hypotension implemented by a processor includes: receiving first clinical data and second clinical data for an individual; extracting a statistical value for the received first clinical data as a first feature; extracting an embedding vector for the received second clinical data as a second feature; and predicting whether the hypotension occurs in the individual within a first period by inputting the first feature and the second feature to a prediction model trained to predict whether the hypotension occurs using the first feature and the second feature as inputs.
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
G16H 10/60 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données spécifiques de patients, p. ex. pour des dossiers électroniques de patients
8.
Method for Providing Information about Angiography and Device Using the Same
Industry-Academic Cooperation Foundation, Yonsei University (République de Corée)
Inventeur(s)
Kim, Kyu Bom
Kim, Kyu Seok
Lee, Su Hwan
Kim, Yeon Kyeong
Abrégé
In the present specification, as an information providing method for angiography which is implemented by a processor, an information providing method for angiography including a step of receiving a projection image of a computed tomography angiography (CTA) of an individual, a step of generating a first extraction image for a blood vessel by inputting the received CTA projection image to a first model which is trained to generate a first extraction image for the blood vessel with a CTA projection image as an input, and a step of generating a rendering image from the first extraction image.
G06V 10/40 - Extraction de caractéristiques d’images ou de vidéos
9.
METHOD AND COMPUTER PROGRAM FOR PREDICTING PARAMETER OF SAMPLE IN OPTICAL MEASUREMENT SYSTEM, AND RECORDING MEDIUM STORING COMPUTER PROGRAM FOR IMPLEMENTING SAME
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Kim, Young-Joo
Jung, Juwon
Kim, Kibaek
Kim, Nagyeong
Abrégé
An embodiment provides a method and a computer program for predicting a parameter of a sample in an optical measurement system, and a recording medium storing the computer program for implementing the same, wherein the method includes: generating library spectral distribution data; supervising learning an artificial neural network with the library spectral distribution data; inputting measurement spectral distribution data acquired by measuring a sample; generating synthetic data by combining the measurement spectral distribution data and similar library spectral distribution data that are similar to the library spectral distribution data; inputting the synthetic data into the supervised learning artificial neural network to predict relative structural parameter coordinates; and combining similar variable measurement parameter coordinates for the similar library spectral distribution data and the predicted relative structural parameter coordinates to output actual variable parameter coordinates.
SUNGKWANG MEDICAL FOUNDATION (République de Corée)
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Kim, Kyuseok
Beom, Jin Ho
You, Je Sung
Abrégé
One aspect provides a pharmaceutical composition for preventing or treating ischemic heart disease, the composition comprising aspartic acid or a pharmaceutically acceptable salt thereof. The pharmaceutical composition significantly reduces the volume of infarcted areas within the myocardium, thereby exhibiting an excellent effect of preventing or treating ischemic heart disease. In addition, by further comprising ornithine or a pharmaceutically acceptable salt thereof, the composition induces a greater reduction in the volume of infarcted areas within the myocardium compared to administering aspartic acid or a pharmaceutically acceptable salt thereof alone, thereby exhibiting a superior effect of preventing or treating ischemic heart disease.
A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
A61P 9/10 - Médicaments pour le traitement des troubles du système cardiovasculaire des maladies ischémiques ou athéroscléreuses, p. ex. médicaments antiangineux, vasodilatateurs coronariens, médicaments pour le traitement de l'infarctus du myocarde, de la rétinopathie, de l'insuffisance cérébro-vasculaire, de l'artériosclérose rénale
A23L 33/125 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sirops d'hydrate de carboneModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sucresModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des alcools de sucreModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
11.
METHOD AND SYSTEM FOR MEASURING BIOMARKERS BY USING SMART CONTACT LENS
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Park, Jang Ung
Park, Won Jung
Seo, Hun Kyu
Song, Ha Young
Abrégé
A system and a method for measuring biomarkers by using a smart contact lens, according to one embodiment of the present invention, comprise: a smart contact lens worn on the eye of a subject so as to measure biomarkers in tears; and a terminal equipped with an application for collecting data of the biomarkers in tears from the smart contact lens, wherein the terminal includes a control unit for controlling that biomarkers in tears are measured after a stabilization time has elapsed from when the smart contact lens is worn on the eye of the subject.
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 10/00 - Instruments pour le prélèvement d'échantillons corporels à des fins de diagnostic Autres procédés ou instruments pour le diagnostic, p. ex. pour le diagnostic de vaccination ou la détermination du sexe ou de la période d'ovulationInstruments pour gratter la gorge
G16H 40/60 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Shin, Dong Jun
Lee, Seung Ryeol
Abrégé
A pneumatic energy generation device includes at least one pneumatic generation unit including a pneumatic supply member that supplies stored pneumatic energy to an actuator, a pneumatic generation member that generates the pneumatic energy by adjusting the pressure of the pneumatic supply member, and at least one pneumatic reinforcement unit including a liquid-gas chamber that receives a liquefied gas and a liquid-fluid chamber that receives a liquid fluid, thereby selectively mixing the liquid fluid into the liquefied gas according to the pressure of the pneumatic supply member to selectively gasify the liquefied gas and increasing the pneumatic energy while cooling the pneumatic generation member.
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
PEOPLE AND TECHNOLOGY INC (République de Corée)
Inventeur(s)
Park, Jin Young
Hong, Kyung Pyo
Abrégé
The present invention relates to an infectious disease transmission zone identification method, and an apparatus using same. The method is an infectious disease transmission zone identification method implemented by a processor, comprising the steps of: receiving at least one stay area for an infectious disease patient; receiving, from a spatial atmospheric pressure measurement sensor, measured atmospheric pressure of the stay area and a first area connected to the stay area so that air flows therebetween; determining that the stay area has either negative pressure or positive pressure on the basis of the atmospheric pressure of the stay area and the first area; and determining a transmission zone for the infectious disease according to whether the stay area has negative pressure or positive pressure.
G16H 50/80 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour la détection, le suivi ou la modélisation d’épidémies ou des pandémies, p. ex. de la grippe
H04W 4/80 - Services utilisant la communication de courte portée, p. ex. la communication en champ proche, l'identification par radiofréquence ou la communication à faible consommation d’énergie
G01L 19/08 - Moyens pour l'indication ou l'enregistrement, p. ex. pour l'indication à distance
14.
ELECTROSPUN NANOFIBER MEMBRANE FOR CORNEAL CELL TRANSPLANTATION
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (USA)
THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (USA)
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Myung, David
Song, Euisun
Koh, Won-Gun
Chen, Karen M.
Abrégé
Electrospun nanofiber membranes are provided. The membranes are electrospun from a suitable biocompatible and biodegradable biopolymer, e.g. gelatin, collagen, etc., to generate a membrane, which is then cross-linked. The membrane may be seeded with cells. The compositions find use tissue regeneration, particularly in repair, regeneration, and/or reconstruction of lamellar or partial defects of wounded corneal tissue.
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Lee, Joon Sang
Cho, Jae Yong
Ko, Seungchul
Lee, Hee Min
Kim, Se Young
Kwon, Soon Wook
Abrégé
The present invention provides a method for predicting ion distribution in a lithium-sulfur battery. In one embodiment, the method for predicting ion distribution in a lithium-sulfur battery may comprise: a first step of forming ion distribution image data in the battery by inputting a boundary value of the battery and an initial value of the battery into a data formation unit that includes a battery internal ion distribution prediction model based on numerical analysis; and a second step of inputting an initial battery state and the ion distribution image data obtained in the first step into an image generation unit so as to output an ion distribution prediction image through an LSTM-based artificial intelligence block.
G16C 10/00 - Chimie théorique computationnelle, c.-à-d. TIC spécialement adaptées aux aspects théoriques de la chimie quantique, de la mécanique moléculaire, de la dynamique moléculaire ou similaires
H01M 10/42 - Procédés ou dispositions pour assurer le fonctionnement ou l'entretien des éléments secondaires ou des demi-éléments secondaires
G06N 3/0442 - Réseaux récurrents, p. ex. réseaux de Hopfield caractérisés par la présence de mémoire ou de portes, p. ex. mémoire longue à court terme [LSTM] ou unités récurrentes à porte [GRU]
G06N 7/01 - Modèles graphiques probabilistes, p. ex. réseaux probabilistes
16.
METHOD FOR TREATING CANCER EXHIBITING HIGH EXPRESSION OF SFRP4
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Cheong, Jae-Ho
Lee, Suji
Jhe, Yoo-Lim
Abrégé
The present invention relates to a method for treating cancer exhibiting high expression of SFRP4. In particular, the present invention was developed through intensive research to identify a highly reliable treatment method for stem cell-type gastric cancer that has the worst prognosis and for which effective therapeutic agents are difficult to develop. As a result, it was confirmed that the cancer stem cell properties decreased when Wnt protein was injected to the MKN1 gastric cancer cell line, which exhibits high expression of SFRP4. In addition, it was confirmed that secreted frizzled-related protein 4 (SFRP4), phosphorylated and secreted by protein kinase A (PKA) can form a complex with β-catenin and TCF4 to increase transcription of Wnt target genes, and by inhibiting PKA to prevent phosphorylation of SFRP4, a decrease in cancer stem cell properties was observed, which leads to the completion of the present invention. The invention can be advantageously used as a novel therapeutic agent for stem cell-type gastric cancer.
G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides
G01N 33/50 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique
A61K 31/472 - Isoquinoléines non condensées, p. ex. papavérine
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Cho, Seung Woo
Kang, Sang Wook
Sung, Hak Joon
Park, Se Won
Yu, Seung Eun
Nam, Yu Jin
Abrégé
The present invention relates to a composition for maturation of adrenal organoids, a method for maturation of adrenal organoids using same, and a method for transplantation of organoids prepared by the method. In the present invention, the structurally and functionally mature adrenal organoids prepared under optimized culture conditions using the composition for maturation of adrenal organoids containing adrenocortical hormone and cyclic adenosine monophosphate have been structurally and functionally improved, and it was confirmed that the adrenal organoid chip having a three-dimensional vascular network structure manufactured using the same actually replaces the function of the adrenal gland without side effects after transplantation into a mouse. Accordingly, the present invention can be advantageously used for transplantation or regenerative therapy, drug screening, drug responsiveness evaluation, and the like.
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Lim, Yong-Beom
Hwang, Hyunsuk
Abrégé
An embodiment relates to a depsipeptide-based building block for inhibiting protein-protein interactions, a nanostructure including the same, and a use thereof, wherein the depsipeptide-based building block may remain in the body and cells for a long time when administered in vivo and be delivered to a target tissue with high efficiency, and a peptide for inhibiting protein-protein interactions may be gradually released over a long time to obtain a high effect.
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Kim, Jong Baeg
Han, Hyun Jun
Hwang, Kyu Hyun
Abrégé
Disclosed are a VACNT transfer method, a VACNT transfer system for the entire substrate, and a VACNT device. The VACNT transfer method comprises: a first step of cooling a substrate to be transferred, to condense and cool water vapor on the surface of the substrate to be transferred, thereby forming an ice layer; and a second step of liquefying the ice layer and then cooling same again, while VACNTs are disposed on the ice layer.
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Yun, Hae Ryong
Yoo, Tae Hyun
Lee, Gyu Bok
Jeon, Myeong Jun
Abrégé
The present invention relates to a method for providing a clinical decision making support system, comprising the steps of: acquiring medical data including a diagnosis history of an object; determining a plurality of treatment guides for the object by inputting the medical data to each of a plurality of medical information providing models trained to determine a treatment guide by using medical data as an input; and providing a user interface including the plurality of treatment guides for the object.
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
G16H 10/20 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des essais ou des questionnaires cliniques électroniques
G16H 10/60 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données spécifiques de patients, p. ex. pour des dossiers électroniques de patients
G16H 70/20 - TIC spécialement adaptées au maniement ou au traitement de références médicales concernant des pratiques ou des directives
G16H 20/00 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients
21.
DEVICE FOR MEASURING OBSTRUCTION OF TRACHEOSTOMY TUBE, TRACHEA, AND BRONCHUS OF PATIENT WITH TRACHEOSTOMY TUBE
THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION (République de Corée)
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Joo, Young Hoon
Kim, Hyun Bum
Kim, Jong Baeg
Jung, Yo Han
Koh, Dae Yeon
Kim, Min Hyeong
Han, Hyun Jun
Abrégé
An embodiment provides a device for measuring the obstruction of a tracheostomy tube, the trachea, and the bronchus, the device comprising an obstruction measurement unit (100) which is coupled to the entrance (11) of a tracheostomy tube where tracheostomy has been performed, and transmits a sound wave and receives a reflected sound wave to measure an obstruction site in any one of the tracheostomy tube (A), the trachea (B), and the bronchus (C).
KOREA GRID FORMING CO., LTD. (République de Corée)
PION ELECTRIC CO., LTD. (République de Corée)
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Kang, Ji Seong
Hur, Kyeon
Abrégé
The present technology relates to a grid-forming power conversion control technology and, more specifically, to a grid-forming power conversion control device and a grid-forming power conversion control method. According to an embodiment, the output frequency of a grid-forming power conversion device can be controlled without a complicated current controller, which enables a simple structure and a high control speed.
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Kim, Jongbaeg
Jung, Yohan
Jo, Eunhwan
Abrégé
A micro-electromechanical system (MEMS) electric field sensor using a resonant torsional shutter and a method of manufacturing the MEMS electric field sensor are described. A method of manufacturing a micro-electromechanical system (MEMS) electric field sensor according an embodiment includes: forming a metal layer on a wafer having a handle layer, a buried oxide layer arranged on the handle layer, and a device layer arranged on the buried oxide layer; patterning the metal layer to form a plurality of electrical pads thereon, forming a comb drive actuator on the device layer, the comb drive actuator including a sensing electrode and a torsional shutter configured to be resonant torsionally driven; forming a driving space of the torsional shutter in the handle layer; and etching and releasing the buried oxide layer.
SAMSUNG ELECTRONICS CO., LTD. (République de Corée)
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Jeon, Taejae
Lee, Jungho
Yoo, Juwoan
Jang, Sungjun
Lee, Sangyoun
Lee, Yongju
Abrégé
An electronic device, according to various embodiments, comprises: a camera module; at least one processor; and a memory, wherein the memory may store instructions that, when executed by the at least one processor, instruct the electronic device to: acquire at least three feature coordinates from a palm image obtained via the camera module; identify a rotation angle of a palm on the basis of the at least three feature coordinates; and adjust a palm print recognition region on the basis of the rotation angle of the palm.
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Oh, Jeong-Do
Lee, Hyun-Kyung
Park, Mi-Ra
Seok, Jang-Hyeon
Park, Jung-Woo
Kim, Hyung-Jun
Chung, Seung-Min
Park, Seon-Yeong
Na, Seung-Gyu
Abrégé
The present disclosure relates to a method of forming a thin film having excellent properties by depositing an organometallic compound (particularly, an organometallic compound containing rare earth metals) and to a thin film formed thereby.
C23C 16/455 - Revêtement chimique par décomposition de composés gazeux, ne laissant pas de produits de réaction du matériau de la surface dans le revêtement, c.-à-d. procédés de dépôt chimique en phase vapeur [CVD] caractérisé par le procédé de revêtement caractérisé par le procédé utilisé pour introduire des gaz dans la chambre de réaction ou pour modifier les écoulements de gaz dans la chambre de réaction
C23C 16/44 - Revêtement chimique par décomposition de composés gazeux, ne laissant pas de produits de réaction du matériau de la surface dans le revêtement, c.-à-d. procédés de dépôt chimique en phase vapeur [CVD] caractérisé par le procédé de revêtement
26.
BACTERIOPHAGE AND BACTERIOPHAGE COCKTAILS AND USES THEREOF
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Kim, Jong Hak
Kang, Du Ru
Abrégé
An embodiment relates to a method for producing a self-assembly polymer membrane by non-solvent induced film formation (NIFF), the method including: (a) preparing a polymer solution by mixing an ionized polymer with an organic solvent, (b) preparing a substrate on which a polymer solution coating layer is formed by coating the polymer solution on a substrate and (c) forming an ionized polymer membrane by immersing the substrate on which the polymer solution coating layer is formed in a non-solvent without going through a drying process under elevated temperature conditions. Accordingly, it is possible to produce a nonporous, dense polymer membrane in an efficient way that saves time and energy.
B29C 41/00 - Façonnage par revêtement d'un moule, noyau ou autre support, c.-à-d. par dépôt de la matière à mouler et démoulage de l'objet forméAppareils à cet effet
B29C 41/08 - Revêtement d'une forme, d'un noyau ou d'un autre support par pulvérisation ou fluidisation, p. ex. pulvérisation de poudre
B29C 41/12 - Étalement de la matière à mouler sur un support
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Baek, Wooyeol
Lee, Won Jai
Kim, Dohyun
Park, Yongkyu
Jo, Han Saem
Shim, Kyu-Sik
Heo, Min
Abrégé
The present invention provides a biocompatible three-dimensional scaffold and a composition for reconstructing lost tissue comprising the same. The scaffold of the present invention provides a mechanical support for a tissue cavity due to its strong physical strength and, at the same time, efficiently induces quantitative restoration of irreversibly lost tissue because the internal space thereof may be filled with active ingredients for tissue regeneration. In addition, when the spherical scaffold of the present invention is used, it may be efficiently inserted into a tissue cavity having any shape, and may also be degraded at an appropriate time after the completion of regeneration, indicating that it is useful as a scaffold for human transplantation for restoring various adipose tissues, including breast tissue.
A61L 27/18 - Matériaux macromoléculaires obtenus par des réactions autres que celles faisant intervenir uniquement des liaisons non saturées carbone-carbone
A61L 27/36 - Matériaux pour prothèses ou pour revêtement de prothèses contenant des constituants de constitution indéterminée ou leurs produits réactionnels
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Jun, Seong Chan
Hwang, Yun Ji
Hwang, Tae Jong
Hong, Jong Woo
Liu, Tianci
Abrégé
An embodiment provides a multi-sensor and an early diagnosis system using the same, wherein the multi-sensor diagnoses a disease by using deep learning technology after obtaining a plurality of different electric signals obtained through reactions with target materials that respectively contact a plurality of sensors equipped in the multi-sensor.
G01N 27/27 - Association de plusieurs systèmes ou cellules de mesure, chacun mesurant un paramètre différent, dans laquelle les résultats des mesures peuvent être, soit utilisès indépendamment, les systèmes ou les cellules étant physiquement associés, soit combinés pour produire une valeur représentative d'un autre paramètre
A61B 5/08 - Dispositifs de mesure pour examiner les organes respiratoires
G01N 33/53 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet
G01N 33/543 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet avec un support insoluble pour l'immobilisation de composés immunochimiques
30.
METHOD AND APPARATUS FOR PERFORMING FULL DUPLEX RADIO IN WIRELESS COMMUNICATION SYSTEM
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Chung, Jaehoon
Min, Byung-Wook
Hwang, Jun
Lee, Jongpil
Abrégé
A method of transmitting and receiving a signal at a terminal in a wireless communication system may be provided. A method of, at a terminal, transmitting and receiving a signal may comprise generating a first signal at transmitting end of the terminal and transmitting the generated first signal through an antenna and receiving a second signal through the antenna and transferring the second signal to a receiving end of the terminal. A differential circulator may be provided between the transmitting end and receiving end and the antenna, and the first signal may be transmitted and the second signal may be received at the same time based on the differential circulator.
H04B 1/56 - Circuits utilisant la même fréquence pour la communication bilatérale avec possibilité de communication simultanée dans les deux directions
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
SEOUL NATIONAL UNIVERSITY HOSPITAL (République de Corée)
SAMSUNG LIFE PUBLIC WELFARE FOUNDATION (République de Corée)
SAMSUNG MEDICAL FOUNDATION (République de Corée)
UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION (République de Corée)
THE ASAN FOUNDATION (République de Corée)
KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (République de Corée)
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DANKOOK UNIVERSITY (République de Corée)
Inventeur(s)
Cheon, Jae Hee
Nam, Chung Mo
Park, Ji Hye
Zhang, Hyun Soo
Kim, Joo Sung
Kim, Young Ho
Park, Dong Il
Ye, Byong Duk
Jeen, Yoontae
Kim, Se Hyun
Abrégé
The present specification provides a method for providing information on ulcerative colitis by means of a processor, the method comprising: a step for receiving a Korean Ulcerative Colitis-Specific Questionnaire (K-UCSQ) score for an individual; and a step for determining an inflammatory bowel disease prognosis for the individual on the basis of the received K-UCSQ score.
G16H 50/30 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le calcul des indices de santéTIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour l’évaluation des risques pour la santé d’une personne
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
G16H 10/20 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des essais ou des questionnaires cliniques électroniques
G16H 10/60 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données spécifiques de patients, p. ex. pour des dossiers électroniques de patients
32.
METHOD FOR PROVIDING INFORMATION ON METACHRONOUS RECURRENCE OF GASTRIC CANCER
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Kim, Jie Hyun
Nahm, Ji Hae
Abrégé
The present specification provides a method for providing information on the metachronous recurrence of gastric cancer, the method comprising the steps of: measuring a level of mRNA of at least one marker gene from among CD8, CD4, and PD-L1 or a protein thereof in a biological sample isolated from a subject; and determining the possibility of metachronous gastric cancer recurrence in the subject on the basis of the measured level of mRNA of the marker gene or protein thereof.
G01N 33/574 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour le cancer
C12Q 1/6886 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour les maladies provoquées par des altérations du matériel génétique pour le cancer
33.
DEVICE AND METHOD FOR DETERMINING IMAGE ANALYSIS POLICY
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Kim, Seonglyun
Jung, Wonhyung
Lee, Seungick
Kook, Sujin
Cho, Taiyong
Kim, Myungjoon
Abrégé
This server device may comprise: a transceiver for transmitting/receiving data to/from at least one robot device; and a controller for controlling the transceiver and selecting an image analysis policy for control of the robot device, wherein the controller collects at least one of state information of a wireless network connected to the robot device, meta information of the robot device, and task characteristic information of the robot device, and determines the image analysis policy on the basis of the collected information.
H04L 67/125 - Protocoles spécialement adaptés aux environnements propriétaires ou de mise en réseau pour un usage spécial, p. ex. les réseaux médicaux, les réseaux de capteurs, les réseaux dans les véhicules ou les réseaux de mesure à distance en impliquant la commande des applications des terminaux par un réseau
H04L 65/65 - Protocoles de diffusion en flux de paquets multimédias, p. ex. protocole de transport en temps réel [RTP] ou protocole de commande en temps réel [RTCP]
34.
METHOD FOR MASS-PRODUCING THERMOELECTRIC ELEMENT WITH NOVEL STRUCTURE
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Kim, Woo Chul
Park, Sung Jin
Choi, You Sung
Abrégé
The present invention provides a method for mass-producing a thermoelectric element with a novel structure, comprising steps in which: (a) a spacer part positioned inside a mold part is filled with thermoelectric powder so that the inner and outer sides of the spacer part are encompassed; (b) a punch part presses the spacer part; (c) spark plasma is used to sinter the thermoelectric powder, thereby generating a sintered body; and (d) the sintered body is cut into predetermined sizes so as to manufacture a plurality of thermoelectric elements.
H10N 10/10 - Dispositifs thermoélectriques comportant une jonction de matériaux différents, c.-à-d. dispositifs présentant l'effet Seebeck ou l'effet Peltier fonctionnant exclusivement par les effets Peltier ou Seebeck
35.
MASS FABRICATION METHOD FOR A SPACER INSERTED THERMOELECTRIC DEVICE
Industry-Academic Cooperation Foundation, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Kim, Woochul
Park, Sungjin
Choi, Yousung
Abrégé
An embodiment provides a mass-manufacturing method of new structure thermoelectric elements, including: (a) filling a thermoelectric material powder so as to surround the inner and outer parts of a spacer portion located inside a mold portion; (b) pressurizing the spacer portion by a punch portion; (c) sintering the thermoelectric material powder using spark plasma to produce a sintered body; and (d) cutting the sintered body to a preset size to manufacture a plurality of thermoelectric elements.
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Choi, Ji Won
Kwon, Jae Sung
Kim, Kwang Mahn
Yang, Song Yi
Abrégé
Provided in the present specification are a method for preparing an orthodontic adhesive composition, and an orthodontic adhesive composition prepared thereby, the method comprising the steps of: using white Portland cement and distilled water so as to prepare white hydrated Portland cement (hPC); mixing the prepared hPC and a silanized glass filler so as to prepare a filler mixture; and mixing the filler mixture and a resin substrate containing a resin monomer, so as to prepare the orthodontic adhesive composition.
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Oh, Seung Jae
Maeng, In Hee
Abrégé
The present disclosure relates to a device and method for precisely measuring skin moisture, and more particularly, to a device and method for precisely measuring skin moisture in which measurement of skin moisture is not affected by pressure applied to the device. A device for precisely measuring skin moisture according to one aspect of the present disclosure may include a main body which is open toward a measurement target and has a hollow portion, a contact part slidably mounted on the main body and having a window provided thereon to come in contact with the measurement target, and a connector which includes an elastic member provided to connect the main body and the contact part and be compressed during sliding of the contact part into the main body.
A61B 5/0507 - Détection, mesure ou enregistrement pour établir un diagnostic au moyen de courants électriques ou de champs magnétiquesMesure utilisant des micro-ondes ou des ondes radio utilisant des micro-ondes ou des ondes térahertz
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
38.
PHENOL GROUP-MODIFIED DECELLULARIZED MUSCLE TISSUE-DERIVED EXTRACELLULAR MATRIX FOR MUSCLE REGENERATION, AND METHOD FOR PREPARING SAME
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Cho, Seung Woo
Choi, Soo Jeong
Lee, Mi Jeong
Choi, Yi Sun
An, Soo Hwan
Abrégé
An embodiment relates to a phenol-modified decellularized muscle tissue-derived extracellular matrix (MEM) for muscle regeneration and a method for preparing same. The phenol group-modified decellularized MEM of the embodiment is characterized by containing components similar to original proteins of muscle tissue for muscle regeneration and forming a hydrogel having a stable porous nanofiber structure through dimerization crosslinking between phenol groups, wherein the hydrogel can effectively treat muscle injury or muscle diseases by being administered or implanted into muscle tissue without causing side effects such as an immune response or liver or kidney dysfunction.
A61L 27/54 - Matériaux biologiquement actifs, p. ex. substances thérapeutiques
A61P 21/00 - Médicaments pour le traitement des troubles du système musculaire ou neuromusculaire
C12N 5/077 - Cellules mésenchymateuses, p. ex. cellules osseuses, cellules de cartilage, cellules stromales médulaires, cellules adipeuses ou cellules musculaires
39.
EXOSOMES COMPRISING MIRNA POOL BASED ON INHIBITION OF TGF-β SIGNALING INVOLVED IN CANCER GROWTH AND METASTASIS, AND COMPOSITION COMPRISING SAME FOR INHIBITING CANCER METASTASIS
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Park, Bo Youn
Shin, Won Ji
Abrégé
The present invention relates to exosomes comprising an miRNA pool based on the inhibition of TGF-β signaling involved in cancer growth and metastasis. The exosomes, which are derived from tripartite motif containing 40 (TRIM40) transformed cells treated with staurosporine, comprise a pool of miRNAs that inhibit the expression of ECM- and EMT-related genes, the miRNAs include miR-1343-3p (which inhibits the expression of TGBR1 and TGFBR2), miR-4285 (which inhibits the expression of the TGFB1 gene), and miR-194-3p (which inhibits the TGF-beta signaling pathway), which inhibit the TGF-beta signaling pathway in cancer cells, thereby comprehensively blocking the expression of EMT- and ECM-related genes by surpassing a one-dimensional method of loading one specific miRNA or a small molecule that exhibits anticancer activity so as to inhibit TGF-beta signaling pathways when the miRNAs are absorbed and delivered into cancer cells, and thus the cancer microenvironment is modulated such that strong anticancer responses can be induced in preclinical settings.
A61K 35/13 - Cellules tumorales, quel que soit le tissu d’origine
A61K 31/7105 - Acides ribonucléiques naturels, c.-à-d. contenant uniquement des riboses liés à l'adénine, la guanine, la cytosine ou l'uracile et ayant des liaisons 3'-5' phosphodiester
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Lee, In Suk
Kim, Han Sang
Choi, Il Seok
Kim, Kyung A
Abrégé
The present specification provides a method for providing information about colorectal cancer, and a kit and a drug screening method that are based thereon, the information provision method comprising the steps of: measuring the level of mRNA of an IgA maturation (IGAM) marker gene for a biological sample isolated from an individual, or the level of protein encoded by the mRNA; and determining the prognosis of colorectal cancer of the individual on the basis of the measured level of mRNA for the marker gene or the measured level of protein encoded by the mRNA.
G01N 33/574 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour le cancer
C12Q 1/6886 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour les maladies provoquées par des altérations du matériel génétique pour le cancer
41.
WEARABLE DEVICE CAPABLE OF SWITCH-CAPACITOR DIRECT CURRENT BOOSTING FOR EFFICIENT USE OF WEARABLE THERMOELECTRIC POWER GENERATING ELEMENT AND OPERATING METHOD THEREOF
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Kim, Woo Chul
Yoon, Jun Young
Kim, Ji Yong
Kim, Eun Kyu
Kang, Bo Min
Abrégé
An embodiment of the present invention provides a technology for configuring a switch-capacitor direct current boosting device together with a thermoelectric element, thereby allowing the connection of a capacitor to vary in each of: a case in which the capacitor stores electricity due to the production of electricity by the thermoelectric element, and a case in which an electric device operates due to the discharge of electricity from the capacitor. A wearable device capable of switch-capacitor direct current boosting for efficient use of a wearable thermoelectric power generating element according to an embodiment of the present invention comprises: a thermoelectric element for generating electricity by contacting a user's body surface; an energy storage module connected to the thermoelectric element and having multiple capacitors for storing the electricity generated by the thermoelectric element; a switch module having multiple switch units and allowing one capacitor among the multiple capacitors and another capacitor to be connected in series or in parallel with each other; and a device unit for receiving electricity from the multiple capacitors when each of the multiple capacitors is connected in series by operation of the switch units.
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
CELLARTGEN INC. (République de Corée)
Inventeur(s)
Cho, Seung Woo
Han, Dai Hoon
Kim, Su Kyeom
Lee, Mi Jeong
Bae, Jung Ho
Jin, Yoon Hee
Abrégé
The present invention relates to a decellularized cancer tissue-derived extracellular matrix scaffold and a use thereof. The decellularized cancer tissue-derived extracellular matrix according to the present invention contains a large amount of a malignant tumor-related extracellular matrix and proliferation and metastasis components that are more distinct than existing mouse-derived scaffolds or decellularized normal tissue-derived scaffolds, thereby achieving a better cancer tissue-specific microenvironment. A cancer organoid cultured using the decellularized cancer tissue-derived extracellular matrix was found to have improved cancer-specific markers, proliferative capacity, size, and secretion of inflammatory cytokines, and better achieve a configuration and phenotype of cancer tissues at a level similar to the actual configuration and phenotype, and thus can be effectively used in disease modeling, drug screening, new drug toxicity evaluation, personalized drug selection, and the like.
C12N 5/00 - Cellules non différenciées humaines, animales ou végétales, p. ex. lignées cellulairesTissusLeur culture ou conservationMilieux de culture à cet effet
G01N 33/50 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique
43.
WEARABLE DEVICE FOR MONITORING GLAUCOMA SUSPECT AND GLAUCOMA SUSPECT MONITORING METHOD
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Lee, Joon Sang
Choi, Wung Rak
Lee, Hyeong Jun
Abrégé
One embodiment of the present invention provides a technique for using a wearable device worn on a finger of a user to measure the blood pressure of the user and use same to determine whether the user is a glaucoma suspect. A wearable device for monitoring glaucoma suspect, according to one embodiment of the present invention, comprises: a housing having a ring shape and having an inner space; a sensor unit coupled to the housing and contacting the skin of a user to measure pulse waves of the user; a communication unit for receiving and processing a signal of the sensor unit to generate a transmission signal which is a transmitted signal; and an analysis unit for receiving and analyzing the transmission signal.
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/021 - Mesure de la pression dans le cœur ou dans les vaisseaux sanguins
A61B 5/024 - Mesure du pouls ou des pulsations cardiaques
A61B 5/02 - Détection, mesure ou enregistrement en vue de l'évaluation du système cardio-vasculaire, p. ex. mesure du pouls, du rythme cardiaque, de la pression sanguine ou du débit sanguin
44.
METHOD FOR PROVIDING INFORMATION ABOUT DEMODEX MITES AND DEVICE FOR PROVIDING INFORMATION ABOUT DEMODEX MITES USING SAME
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Kim, Je Min
Lee, Ju Hee
Lee, Yun Na
Park, Chang Ook
Kim, Ji Hee
Lee, Young In
Lee, Chang Yoon
Abrégé
The present invention comprises a method for providing information about demodex mites and a device based on the method, the method comprising the steps of: extracting a first feature of the demodex mites by inputting a face image of an individual to a trained first prediction model; generating a saliency map from the first feature; acquiring regions of interest in the face as one or more patches; extracting a second feature of the demodex mites by inputting the one or more patches to a second prediction model; and predicting a final density probability of the demodex mites for the individual by inputting the first feature and the second feature to a third prediction model trained to predict the density probability of the demodex mites for the individual.
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
G16H 50/50 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour la simulation ou la modélisation des troubles médicaux
G16H 30/20 - TIC spécialement adaptées au maniement ou au traitement d’images médicales pour le maniement d’images médicales, p. ex. DICOM, HL7 ou PACS
45.
THERMAL RUNAWAY DETECTION AND CONTROL DEVICE AND METHOD THEREOF
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Lee, Woo Young
Shin, Kyu Sik
Abrégé
The present disclosure relates to a thermal runaway of lithium-ion battery detection and control device including: sensor modules for detecting and monitoring hydrogen concentrations of battery cells and each having a palladium-based nano sensor and a communication unit; and a battery cell controller for turning on and off charging/discharging switches of the battery cells according to the hydrogen concentrations detected through the sensor modules and variations in the hydrogen concentrations according to time, wherein the palladium-based nano sensor detects the hydrogen concentration between 20 and 400 ppm.
G01N 27/12 - Recherche ou analyse des matériaux par l'emploi de moyens électriques, électrochimiques ou magnétiques en recherchant l'impédance en recherchant la résistance d'un corps solide dépendant de l'absorption d'un fluideRecherche ou analyse des matériaux par l'emploi de moyens électriques, électrochimiques ou magnétiques en recherchant l'impédance en recherchant la résistance d'un corps solide dépendant de la réaction avec un fluide
B82Y 15/00 - Nanotechnologie pour l’interaction, la détection ou l'actionnement, p. ex. points quantiques comme marqueurs en dosages protéiques ou moteurs moléculaires
G01N 33/00 - Recherche ou analyse des matériaux par des méthodes spécifiques non couvertes par les groupes
H01M 10/42 - Procédés ou dispositions pour assurer le fonctionnement ou l'entretien des éléments secondaires ou des demi-éléments secondaires
SUNGKYUNKWAN UNIVERSITY RESEARCH & BUSINESS FOUNDATION (République de Corée)
INDUSTRY-ACADEMICCOOPERATION FOUNDATION,YONSEIUNIVERSITY (République de Corée)
Inventeur(s)
Kim, Hui Kwon
Lee, Junwon
Byeon, Suk Ho
Jeong, Han
Kim, Jisung
Abrégé
One of the most important technical problems to be solved in the present specification is that of providing a prime editor capable of exhibiting an actual therapeutic effect by selecting a prime editor exhibiting an effect of correcting c.4957dupA mutation of an EYS gene of actual human retinal cells from among numerous theoretically designable prime editors and specifying a configuration thereof. In order to solve this technical problem, the present specification provides a prime editor and a component thereof, wherein the prime editor is screened through a high-throughput screening method, is verified in actual human retinal cells, and can actually correct the c.4957dupA mutation of the EYS gene. The prime editor disclosed in the present specification acts on human retinal cells including the c.4957dupA mutation in the EYS gene, thereby being able to correct the EYS gene to a normal state. Therefore, the prime editor can be used as a therapeutic agent for retinitis pigmentosa caused by the c.4957dupA mutation in the EYS gene.
C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
A61K 31/7088 - Composés ayant au moins trois nucléosides ou nucléotides
A61K 48/00 - Préparations médicinales contenant du matériel génétique qui est introduit dans des cellules du corps vivant pour traiter des maladies génétiquesThérapie génique
METHOD FOR ISOLATING, MAINTAINING, PROLIFERATING, AND DIFFERENTIATING MONOCLONAL CELLS DERIVED FROM HUMAN SALIVARY GLAND EPITHELIAL STEM CELLS OR PROGENITOR CELLS AND PRODUCTION METHOD FOR EXTRACELLULAR VESICLES FOR TREATING SALIVARY GLAND DISEASES
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Lim, Jae-Yol
Yoon, Yeo-Jun
Hong, Yongpyo
Jeong, Ye-Jin
Abrégé
The present disclosure relates to a method for isolating, maintaining, proliferating and differentiating monoclonal cells derived from human salivary gland epithelial stem cells or progenitor cells, and a production method for extracellular vesicles for treating salivary gland diseases. More specifically, conditions for isolating monoclonal salivary gland epithelial cells through an optimized subfractionation culturing method from a small amount of major salivary gland or minor salivary gland tissue obtained during surgery or biopsy processes have been established, and culture medium conditions for enabling long-term culture of salivary gland epithelial stem cells or progenitor cells in 2D have been established. Such high-purity monoclonal cells derived from human salivary gland epithelial stem cells or precursor cells are expected to be utilized not only as cell therapy products for fundamental treatment of salivary gland dysfunction and as candidates for extracellular vesicles, but also widely throughout salivary gland studies such as disease modeling, pathology research, drug screening, toxicity evaluation, and genetic manipulation.
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Gee, Heon Yung
Park, Hyun Woo
Oh, Jongwook
Sub, Yujin
Abrégé
The present invention relates to the discovery of an agent for measuring the expression level of a protein that induces the acquisition of metastatic ability by tumor cells, or a gene encoding the same, and a method for preventing or treating metastatic cancer by controlling the expression of the protein or gene. The present invention provides effective biomarkers for metastatic cancer that are capable of significantly improving the patient's survival rate when detected early, and provides a method capable of predicting with high reliability the likelihood that primary cancer will progress to metastatic cancer. Thus, the present invention may be useful for efficient prevention or treatment of metastatic cancer by inhibiting the expression of these factors.
C12Q 1/6886 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour les maladies provoquées par des altérations du matériel génétique pour le cancer
G01N 33/574 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour le cancer
49.
BIOGAS PRODUCTION DEVICE INCLUDING CONDUCTIVE SUPPORT-BASED DYNAMIC MODULE AND BIOGAS PRODUCTION METHOD USING SAME DEVICE
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Kim, Sang-Hyoun
Kim, Saint Moon
Sim, Young-Bo
Yang, Jisu
Abrégé
Embodiments include a biogas production device including a conductive support-based dynamic biofilm with improved biogas productivity by using, as a support, a conductive support having a surface on which a dynamic biofilm of an electroactive microbial community is formed, and a biogas production method using the device. The biogas production device comprises: a reaction tank for producing an organic wastewater mixture by mixing organic wastewater and anaerobic microbial community formation to produce biogas; a dynamic biofilm module for filtering the organic wastewater mixture transferred from the reaction tank using a porous conductive support having a dynamic biofilm formed on a surface thereof; and a storage tank for measuring and storing an amount of biogas produced in the reaction tank.
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
SEOUL NATIONAL UNIVERSITY HOSPITAL (République de Corée)
SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (République de Corée)
SAMSUNG MEDICAL CENTER (République de Corée)
RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY (République de Corée)
Inventeur(s)
Ryu, Han Suk
Jung, Min Sun
Lee, Hye Bin
Lee, Jae Seok
Abrégé
The present invention provides a composition for differential diagnosis of urothelial papilloma, and an information provision method using same. By using the composition and the information provision method of the present invention, urothelial papilloma can be distinguished from low-grade urothelial carcinoma, which had been difficult to distinguish by tumor morphological shape in a conventional histopathological examination.
G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides
C12Q 1/6883 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour les maladies provoquées par des altérations du matériel génétique
51.
IMMUNITY-ENHANCING PEPTIDE ANALOGS AND USES THEREOF
RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY (République de Corée)
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Bae, Yoe Sik
Yun, Nam Joo
Cho, Hyeon Jin
Choi, Soo Hyuk
Yoon, Hye Rim
Choi, Hee Won
Seo, Eun Jin
Abrégé
The present invention relates to a WKYMVm peptide analog comprising an amino acid sequence of Trp (W)-Lys (K)-Tyr (Y)-Met (M)-Val (V)-D-Met (m), in which at least one amino acid residue selected from the group consisting of Lys (K), Tyr (Y), and Met (M) in the amino acid sequence is substituted with a β3-amino acid residue or a peptoid residue, and a use thereof. The WKYMVm peptide analogs of the present invention has effects of increasing stability by increasing in vivo degradation half-life and of promoting activation of innate immune responses by neutrophils through activation of formyl peptide receptors, and thus can be effectively used in preventing or treating a disease that is be prevented or treated by formyl peptide receptors, especially an infectious disease or inflammatory disease.
Industry-Academic Cooperation Foundation, Yonsei University (République de Corée)
Inventeur(s)
Kim, Baek Gil
Cho, Nam Hoon
Jang, Yeonsue
Kang, Suki
Abrégé
The present invention provides an endoscopic pipette and an observation system, the endoscopic pipette is configured to remove a culture medium accommodated in a culture vessel, in which spheroids are cultured, and observe the spheroids in the culture vessel, and the endoscopic pipette includes a tip unit configured to be inserted into the culture vessel to extract the culture medium, an accommodation unit configured to accommodate the culture medium extracted by the tip unit, a camera unit provided between the tip unit and the accommodation unit, disposed adjacent to the tip unit, and configured to capture an image of an interior of the culture vessel, and a power unit provided in a partial space of the accommodation unit and configured to provide power to the camera unit.
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Hong, Jinkee
Abrégé
The present disclosure relates to a cell obtaining method for creating NFT based on a cell image. The cell obtaining method includes the steps of separating a cell from a biological sample, obtaining a stem cell by treating the cell with a dedifferentiation inducer, differentiating the stem cell, acquiring an image of the differentiated cell; and converting the image of the differentiated cell into an NFT image, and creates the NFT using a vital image in a simple and easy way through non-invasive and non-medical procedures.
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Kim, Hye Ryun
Lee, In Suk
Ha, Sang Jun
Cha, Jun Ha
Koh, Yoon Woo
Abrégé
KLRB1KLRB1 mRNA or a protein encoded by the mRNA or CD161+ tissue-resident memory T cells as a marker for predicting a response to immunotherapy in HPV-induced cancer.
G01N 33/574 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour le cancer
C12Q 1/70 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des virus ou des bactériophages
C12Q 1/6886 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour les maladies provoquées par des altérations du matériel génétique pour le cancer
C12Q 1/6881 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour le typage de tissu ou de cellule, p. ex. sondes d’antigène leucocytaire humain [HLA]
C07K 16/28 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant d'animaux ou d'humains contre des récepteurs, des antigènes de surface cellulaire ou des déterminants de surface cellulaire
A61K 39/00 - Préparations médicinales contenant des antigènes ou des anticorps
55.
DNA CLOCKS CAPABLE OF LONG-TERM TIMEKEEPING COMPRISING A COMPOSITION FOR MEASURING OR PREDICTING THE DURATION OF CELLULAR EVENTS IN CELLS
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Kim, Hyongbum
Park, Ji-Hye
Lee, Hanahrae
Abrégé
Disclosed are a DNA clock capable of recording long periods of time, comprising a composition for measuring or estimating elapsed time in cells, and a method of measuring or estimating elapsed time in cells using the composition.
C12Q 1/6897 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des acides nucléiques faisant intervenir des gènes rapporteurs liés de façon fonctionnelle à des promoteurs
C12Q 1/6811 - Méthodes de sélection pour la production ou l’élaboration d’oligonucléotides spécifiques cibles ou de molécules de liaison
C12Q 1/6874 - Méthodes de séquençage faisant intervenir des réseaux d’acides nucléiques, p. ex. séquençage par hybridation [SBH]
Industry-Academic Cooperation Foundation, Yonsei University (République de Corée)
Inventeur(s)
Kang, Seok-Gu
Sung, Hak-Joon
Baek, Sewoom
Abrégé
This application relates to a tumor tissue model in which tumor tissue isolated from a patient can be cultured. The tumor tissue model uses tumor tissue isolated from a patient, and thus the tumor tissue can be cultured while maintaining the extracellular matrix of tumor cells. Since the tumor tissue is cultured in an environment similar to the actual environment inside the body, the tumor tissue model can be used for patient-tailored drug screening, drug response evaluation, radiation reactivity evaluation, tumor-related research, clinical evaluation, animal replacement tests, disease modeling, etc.
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Kim, Je Min
Lee, Ju Hee
Kim, Ji Hee
Lee, Yun Na
Park, Chang Ook
Oh, In Rok
Choi, Ye Seul
Abrégé
The present invention relates to a method by which a processor of a Demodex folliculorum prediction device provides information about Demodex folliculorum, and provides a method for providing information about Demodex folliculorum, and a device based thereon, the method comprising the steps of: receiving a face image of an individual; acquiring, as one or more patches, regions of interest in the face from the received face image; inputting the face image and each of the patches into a plurality of first density prediction models trained to input the face image and each of the patches so as to predict the density probability of Demodex folliculorum, thereby making a first prediction about the density probability of Demodex folliculorum for the face image and each of the patches; and inputting the density probability of Demodex folliculorum for the face image and each of the patches into a single second density prediction model trained to input the density probability of a plurality of Demodex folliculorums so as to predict the density probability of Demodex folliculorum for an individual, thereby making a second prediction about the density probability of the final Demodex folliculorum.
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
G16H 30/20 - TIC spécialement adaptées au maniement ou au traitement d’images médicales pour le maniement d’images médicales, p. ex. DICOM, HL7 ou PACS
G06N 20/20 - Techniques d’ensemble en apprentissage automatique
58.
MANAGEMENT SYSTEM FOR GENERATING AND DISTRIBUTING CELL IMAGE-BASED NFT
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Hong, Jinkee
Abrégé
The present disclosure relates to a management system for generating and distributing a cell image-based NFT including a cell image generation unit that generates an image from a collected cell, an NFT issuance unit that converts the cell image into an NFT image and stores and manages the NFT image, and an NFT transaction unit that brokers an online transaction for the issued NFT, and a service providing method thereof, and may assign an asset value to a vital image to meet the demand for owning the image.
G06V 20/69 - Objets microscopiques, p. ex. cellules biologiques ou pièces cellulaires
G06F 21/10 - Protection de programmes ou contenus distribués, p. ex. vente ou concession de licence de matériel soumis à droit de reproduction
H04L 9/32 - Dispositions pour les communications secrètes ou protégéesProtocoles réseaux de sécurité comprenant des moyens pour vérifier l'identité ou l'autorisation d'un utilisateur du système
59.
COMPOSITION FOR FIXATIVE EXCHANGE OF PFA-FIXED OR FFPE-TREATED BIOLOGICAL SAMPLES, AND METHOD THEREFOR
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Sohn, Chang Ho
Park, Han Eol
Lee, Yu Tak
Abrégé
The present invention relates to a composition for fixative exchange, comprising an organic catalyst and a platinum-based cross-linking agent. The composition of the present invention allows site-selective binding without interfering with Watson-Crick base pairs of nucleic acids and allows nucleic acids having reacted with a fixative to be restored to the state before reacting with the fixative, thereby enabling reverse transcription efficiency to be maximized, and thus can be effectively used in the field of diagnosing diseases or discovering a target material for new drug development through transcriptome analysis or multi-omics analysis from a single cell or a single nucleus.
Industry-Academic Cooperation Foundation, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Cho, Seung Woo
Jin, Yoon Hee
Choi, Yi Sun
Park, Eun Ju
Abrégé
A composition comprising a decellularized uterine tissue-derived extracellular matrix and a use thereof and, more specifically, a hydrogel composition for three-dimensional culturing an endometrial organoid, a preparation method therefor, and a use thereof are described. The hydrogel composition comprising a decellularized uterine tissue-derived extracellular matrix can be utilized to fabricate an endometrial organoid highly similar to in vivo uterine tissues and organs through the properties, components, and physical properties of the decellularized uterine tissue-derived extracellular matrix, and such endometrial organoids can be advantageously used for in-vivo implantation and in drug tests for various uterus-related diseases.
C12N 5/071 - Cellules ou tissus de vertébrés, p. ex. cellules humaines ou tissus humains
C12N 5/00 - Cellules non différenciées humaines, animales ou végétales, p. ex. lignées cellulairesTissusLeur culture ou conservationMilieux de culture à cet effet
61.
MANUFACTURING METHOD FOR EUGENOL-INCORPORATED FRAGRANCE MICROCAPSULE COMPOSED OF POLYHYDROALKANOATES
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Park, Moo Suk
Lee, Sang Guk
Kim, Hey Soo
Abrégé
Provided herein are a method for providing information on recovery from acute kidney injury and a kit therefor, the method including the steps of: measuring a level of at least one amino acid of glutamine, glutamic acid, arginine, and tryptophan at a predetermined time with respect to a biological sample isolated from an individual; and determining whether there is a possibility of recovery from acute kidney injury (AKI) for the individual within a predetermined period of time on the basis of the measured level of amino acids.
G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides
G01N 33/70 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir la créatine ou la créatinine
63.
GLUCOSE MONITORING SENSOR OF VOLTAGE MEASUREMENT TYPE INCLUDING A SUPERCAPACITOR AND A CONTINUOUS MEASUREMENT METHOD OF GLUCOSE USING THE SAME
Industry-Academic Cooperation Foundation, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Park, Jin Woo
Kil, Hye Jun
Abrégé
A voltage measurement type glucose sensor comprises a microneedle array including a flat part and a plurality of microneedles located on one surface of the flat part; an enzyme layer located on a surface of the plurality of microneedles and including glucose oxidase; a supercapacitor located on the other side of the flat part; and a wireless communication module electrically connected to the supercapacitor, and a glucose measurement method using the same. The glucose sensor is self-driving without the need to apply separate external power, improving the lifespan of the device and enabling close monitoring of accurate glucose levels in real time,
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
64.
SMALL DNA CLOCKS COMPRISING A COMPOSITION FOR MEASURING OR PREDICTING THE DURATION OF CELLULAR EVENTS IN CELLS
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Kim, Hyongbum
Park, Ji-Hye
Lee, Hanahrae
Abrégé
Please enter in the present application the English translation of the abstract of the Korean language application that was filed in the USPTO on Jun. 12, 2024, as contained in the English translation of the application in Appendix B of the Translator Certificate filed herewith, and as separately filed herewith in .docx format (728_Patent_Application_ABSTRACT.docx).
C12N 15/11 - Fragments d'ADN ou d'ARNLeurs formes modifiées
C12Q 1/44 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir une hydrolase une estérase
65.
NOVEL GENE THAT REGULATES BLOOD-BRAIN BARRIER PASSAGE OF CRYPTOCOCCUS NEOFORMANS AND USE THEREOF
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
AMTIXBIO CO., LTD. (République de Corée)
Inventeur(s)
Bahn, Yong Sun
Yu, Seong Ryong
Lee, Kyung Tae
Lee, Jong Seung
Abrégé
The present invention relates to a method for screening for an inhibitor against the blood-brain barrier passage of Cryptococcus neoformans, a method for screening for an antifungal agent, and an antifungal composition. The screening method of the present invention uses a novel gene that regulates the blood-brain barrier passage of Cryptococcus neoformans, and thus can effectively screen for an inhibitor against blood-brain barrier passage and an antifungal agent.
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Kim, Han Sang
Kim, Kyung-A
Ahn, Joong Bae
Paik, Soon Myung
Yong, Dong Eun
Lee, Hyukmin
Abrégé
Provided are: a peptide targeting Fusobacteria, comprising a peptide consisting of an amino acid sequence selected from the group consisting of SEQ ID NOs: 77 to 83; a composition for diagnosing cancer, comprising same; and a drug delivery composition. The peptide targeting Fusobacteria accurately targets Fusobacteria, which are harmful bacteria in various diseases, including cancer, and thus can be effectively used in cancer diagnosis and drug delivery.
G01N 33/574 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour le cancer
C12N 7/00 - Virus, p. ex. bactériophagesCompositions les contenantLeur préparation ou purification
G01N 33/569 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour micro-organismes, p. ex. protozoaires, bactéries, virus
67.
ORGANIC MATERIAL FOR SEMICONDUCTOR CMP, AND SLURRY COMPOSITION COMPRISING SAME
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Kim, Byeong-Su
Abrégé
Provided in one embodiment of the present invention is a polymer micelle having a micelle structure composed of an amphiphilic material with both a hydrophilic group and a hydrophobic group, wherein the hydrophilic group includes a polyglycerol functional group, and the hydrophobic group includes a phenol group having a hydrophobic substituent bonded to the end thereof and modified to be hydrophobic.
C07C 41/03 - Préparation d'éthers à partir d'oxiranes par réaction d'un cycle oxirane avec un groupe hydroxyle
C07C 43/23 - Éthers une liaison sur l'oxygène de la fonction éther étant sur un atome de carbone d'un cycle aromatique à six chaînons contenant des groupes hydroxyle ou O-métal
68.
SYSTEM FOR REDUCING NOISE OF CBCT IMAGE AND METHOD THEREFOR
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Lee, Joon Sang
Choi, Yoon Jeong
Ryu, Susie
Kim, Jun Hong
Abrégé
The present invention relates to a system for reducing noise of a CBCT image and a method therefor, wherein the system can reduce noise of a CBCT image by applying the difference between the CBCT image and a CT image to artificial intelligence learning by using CYCLE GAN so as to convert CBCT image data such that it has the same standards as CT image data and provide same, the CBCT image data having low quality and more noise than the CT image data.
A61B 6/00 - Appareils ou dispositifs pour le diagnostic par radiationsAppareils ou dispositifs pour le diagnostic par radiations combinés avec un équipement de thérapie par radiations
Industry-Academic Cooperation Foundation, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Park, Gyo Khang
Sohn, Il
Abrégé
In an embodiment, gas emitted during DRI processing and melting is collected and blown in refining, and gas emitted from the refining is collected and used in DRI processing, so that it is possible to circulate gas input to and emitted from each process in a DRI-Smelter-BOF (Basic Oxygen Furnace) scheme and achieve process optimization.
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Park, Gyo Khang
Sohn, Il
Abrégé
An embodiment provides a method and a system device for refining molten iron, wherein hydrogen reduction DRI is utilized to collect CO2 gas generated during melting and further reduction and use the gas in decarbonization refining, so as to optimize processes and achieve carbon neutrality. In addition, it is possible to predict the end point of the decarbonization refining by measuring the amount of CO gas generated in decarbonization refining.
Industry-Academic Cooperation Foundation, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Park, Hyung Ho
Kim, Min Jae
Kim, Dong Eun
Kim, Geon Woo
Abrégé
Provided is a Mott-piezo memristor of an ABO3/CO composition, which has maximized piezo characteristics by using a method, such as doping, with various elements, an ABO3 material having a perovskite structure exhibiting Mott-transition characteristics, and inserting a CO interlayer. The Mott-piezo memristor may comprise: a bottom electrode; a top electrode arranged to face the bottom electrode; and a plurality of Mott layers and a plurality of piezoelectric layers, which are arranged between the bottom electrode and the top electrode, wherein the plurality of piezoelectric layers are arranged between the plurality of Mott layers
H10N 70/00 - Dispositifs à l’état solide n’ayant pas de barrières de potentiel, spécialement adaptés au redressement, à l'amplification, à la production d'oscillations ou à la commutation
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Lee, Hyungsuk
Cho, Seung-Woo
Kang, Byungjun
Shin, Jisoo
Rhyou, Chanryeol
Abrégé
Present disclosure provides an apparatus for manufacturing an artificial tissue, comprising:
a hydrogel accommodating structure which accommodates hydrogel including cells and has a bottom plate, a container and a cover; and a standing wave adding means for adding a standing wave to the hydrogel accommodated in the hydrogel accommodating structure, wherein cells in the hydrogel are aligned by the adding of a standing wave, and the position of the cells in the hydrogel is controlled by adjusting at least one of the attenuation coefficient of the container and the reflection coefficient of the cover.
C12M 1/42 - Appareils pour le traitement de micro-organismes ou d'enzymes au moyen d'énergie électrique ou ondulatoire, p. ex. magnétisme, ondes sonores
B01L 3/00 - Récipients ou ustensiles pour laboratoires, p. ex. verrerie de laboratoireCompte-gouttes
C12M 1/12 - Appareillage pour l'enzymologie ou la microbiologie avec des moyens de stérilisation, filtration ou dialyse
C12M 3/00 - Appareillage pour la culture de tissus, de cellules humaines, animales ou végétales, ou de virus
73.
COMPOSITION FOR PREVENTION OR TREATMENT OF ATOPIC DERMATITIS COMPRISING AKT SIGNALING PATHWAY INHIBITOR AS ACTIVE INGREDIENT
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Park, Chang Ook
Kim, Yu Ri
Kim, Su Min
Kim, Hye Li
Zhang, Kelun
Abrégé
The present invention relates to a composition for preventing or treating inflammatory or autoimmune skin disease. The composition of the present invention may be useful as a fundamental therapeutic composition that is able to efficiently ameliorate skin tissue damage caused by inflammation while having a minimized impact on systemic immune activity by specifically inhibiting the activity of skin-specific T cells. The present invention also provides a screening method capable of quickly and highly reliably identifying promising therapeutic candidates that are able to alleviate various autoimmune and inflammatory damages occurring in skin tissue by inhibiting the activity of skin-specific T cells.
A61K 31/517 - PyrimidinesPyrimidines hydrogénées, p. ex. triméthoprime condensées en ortho ou en péri avec des systèmes carbocycliques, p. ex. quinazoline, périmidine
A61K 8/49 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques contenant des composés hétérocycliques
A61P 17/00 - Médicaments pour le traitement des troubles dermatologiques
A61Q 17/00 - Préparations protectricesPréparations employées en contact direct avec la peau pour protéger des influences extérieures, p. ex. des rayons du soleil, des rayons X ou d'autres rayons nuisibles, des matériaux corrosifs, des bactéries ou des piqûres d'insectes
G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides
74.
HIGHLY SENSITIVE SELF-POWERED PRESSURE SENSOR AND THE USE OF THE SAME
Industry-Academic Cooperation Foundation, Yonsei University (République de Corée)
Inventeur(s)
Park, Jin-Woo
Lee, Soyeon
Abrégé
Provided is a self-powered pressure sensor which may show excellent pressure sensitivity by significantly improving transfer efficiency of charges generated by triboelectrification, the sensor including: a first electrode; a first triboelectrification unit positioned on the first electrode; a second triboelectrification unit including a pattern on which a microstructure is repeatedly positioned, the microstructure being reversibly in contact with or separated from the first triboelectrification unit by a physical external force, and having at least one surface in contact with the first triboelectrification unit to induce a change in a contact area; and a second electrode positioned inside the second triboelectrification unit and conformally positioned on a surface of the microstructure, wherein the first electrode and the second electrode are geometrically asymmetric to each other.
A61B 5/024 - Mesure du pouls ou des pulsations cardiaques
A61B 5/0245 - Mesure du pouls ou des pulsations cardiaques utilisant des capteurs engendrant des signaux électriques
G01H 17/00 - Mesure des vibrations mécaniques ou des ondes ultrasonores, sonores ou infrasonores non prévue dans les autres groupes de la présente sous-classe
75.
PHOTOBIOLOGICAL HYDROGEN PRODUCTION METHOD BASED ON CELL ENGINEERING
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Ahn, Hyun Seo
Ryu, Won Hyoung
Gwon, Hyo Jin
Yun, Jae Hyoung
Abrégé
The present invention pertains to: an engineered cell comprising a chloroplast-containing cell and a conductor inserted into the cell, wherein the conductor is inserted so as to contact or penetrate the thylakoid membrane of the chloroplast, whereby the engineered cell is engineered so that photosynthetic electrons can be extracted out of the cell by light; a metal catalyst using the engineered cell; and a hydrogen production method using the engineered cell. By using the metal catalyst according to the present invention, oxygen generated during photosynthesis can be catalyzed and self-regulated at a low concentration and protons can be catalyzed to provide a hydrogen production system and method that enable sustained hydrogen production. In addition, the present invention has the effect of providing an artificial photosynthesis system which can convert sunlight into fuel by consuming only CO2 and water as electron sources and is especially superior in terms of cost efficiency and the immediate availability of the produced fuel.
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Lee, Eun Jig
Kim, Daham
Abrégé
The present invention relates to an autoimmune disease animal model and a method for preparing the same. The animal model of the present invention efficiently generates an autoantibody that causes autoimmune disease, by introducing an autoantigen-encoding gene through the Cre-LoxP system, which enables stable and continuous expression of the autoantigen at a desired time by treatment of Cre recombinase. Contrary to the conventional method that fails to effectively produce autoantibody due to leaky expression and immune tolerance, or requires repeated administration over several weeks, the present invention achieves sustainable expression of an effective amount of autoantigen by only one TAT-Cre recombinase treatment, thus may be utilized as an outstanding animal model reproducing various symptoms and molecular mechanisms of autoimmune diseases.
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Kim, Byeong-Su
Abrégé
An embodiment of the present invention provides a method for mechanochemical decomposition of polyvinyl chloride (PVC) using ball milling, the method comprising the steps of: ball milling PVC and a dechlorinating agent to obtain dechlorinated PVC; ball milling the dechlorinated PVC and an epoxidizing agent to obtain epoxidized PVC; and hydrolyzing the epoxidized PVC.
C08J 11/26 - Récupération ou traitement des résidus des polymères par coupure des chaînes moléculaires des polymères ou rupture des liaisons de réticulation par voie chimique, p. ex. dévulcanisation par traitement avec une substance organique par traitement avec des composés organiques contenant de l'oxygène contenant des groupes acide carboxylique, leurs anhydrides ou esters
C08F 236/04 - Copolymères de composés contenant plusieurs radicaux aliphatiques non saturés et l'un au moins contenant plusieurs liaisons doubles carbone-carbone le radical ne contenant que deux doubles liaisons carbone-carbone conjuguées
78.
PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT
KOREA RESERARCH INSTITUTE OF CHEMICAL TECHNOLOGY (République de Corée)
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Lee, Kwangho
Duggirala, Krishna Babu
Choi, Gil Don
Chae, Chong Hak
Jung, Myoung Eun
Lee, Yujin
Cho, Byoung Chul
Abrégé
A pyrimidine derivative, a method for preparing the pyrimidine derivative, and a pharmaceutical composition comprising the pyrimidine derivative are disclosed. Also disclosed is a method for preventing or treating cancer which includes administering the pyrimidine derivative or a composition containing the pyrimidine derivative to a subject in need of cancer treatment or prevention. The pyrimidine derivative exhibits a high inhibitory ability against EGFR mutation and HER2 mutation, and thus can be effectively used in treatment of cancer in which EGFR mutation and HER2 mutation have occurred
A61K 31/505 - PyrimidinesPyrimidines hydrogénées, p. ex. triméthoprime
A61K 31/506 - PyrimidinesPyrimidines hydrogénées, p. ex. triméthoprime non condensées et contenant d'autres hétérocycles
A61K 31/5377 - 1,4-Oxazines, p. ex. morpholine non condensées et contenant d'autres hétérocycles, p. ex. timolol
A61K 45/06 - Mélanges d'ingrédients actifs sans caractérisation chimique, p. ex. composés antiphlogistiques et pour le cœur
C07D 401/12 - Composés hétérocycliques contenant plusieurs hétérocycles comportant des atomes d'azote comme uniques hétéro-atomes du cycle, au moins un cycle étant un cycle à six chaînons avec un unique atome d'azote contenant deux hétérocycles liés par une chaîne contenant des hétéro-atomes comme chaînons
C07D 401/14 - Composés hétérocycliques contenant plusieurs hétérocycles comportant des atomes d'azote comme uniques hétéro-atomes du cycle, au moins un cycle étant un cycle à six chaînons avec un unique atome d'azote contenant au moins trois hétérocycles
C07D 403/12 - Composés hétérocycliques contenant plusieurs hétérocycles, comportant des atomes d'azote comme uniques hétéro-atomes du cycle, non prévus par le groupe contenant deux hétérocycles liés par une chaîne contenant des hétéro-atomes comme chaînons
C07D 417/12 - Composés hétérocycliques contenant plusieurs hétérocycles, au moins un cycle comportant des atomes de soufre et d'azote comme uniques hétéro-atomes du cycle, non prévus par le groupe contenant deux hétérocycles liés par une chaîne contenant des hétéro-atomes comme chaînons
79.
CONVERSION DEVICE FOR CONVERTING TREATMENT BEAM FOR TREATING LESION OF SUBJECT
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
SAMSUNG LIFE PUBLIC WELFARE FOUNDATION (République de Corée)
Inventeur(s)
Lim, Young Kyung
Kim, Myeong Soo
Park, Kyeong Yun
Kim, Do Hyeon
Kim, Sang Soo
Kim, Hak Soo
Jeong, Jong Hwi
Lee, Se Byeong
Shin, Dong Ho
Kim, Joo Young
Kim, Tae Hyun
Moon, Seong Ho
Suh, Yang-Gun
Kim, Hojin
Jo, Kwanghyun
Abrégé
The present invention relates to a conversion device for converting a treatment beam for treating a lesion of a subject, comprising: a collimator unit to which the treatment beam is incident and which has a plurality of slits; and a scattering unit that scatters the treatment beam that has passed through the collimator unit.
Industry-Academic Cooperation Foundation, YONSEI UNIVERSITY (République de Corée)
THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION (République de Corée)
Inventeur(s)
Kim, Jong Baeg
Koh, Dae Yeon
Jung, Yo Han
Han, Hyun Jun
Joo, Young Hoon
Kim, Hyun Bum
Abrégé
A system for determining a sputum type using a respiratory sound according to an embodiment may comprise a data collection unit that collects respiratory sound data from a patient who has undergone tracheostomy; an image conversion unit that receives the respiratory sound data collected by the data collection unit and converts the received respiratory sound data into a spectrogram image; and a sputum type determination unit that determines a sputum type of the patient who has undergone tracheostomy using a deep learning model based on a pattern difference between the spectrogram images converted by the image conversion unit.
INDUSTRY ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Yoon, Sang Sun
Choi, Jun Yong
Yoon, Mi Young
Jeong, Uk Jin
Abrégé
The present invention provides an antibacterial composition including two or more strains selected from the group consisting of Anaerostipes hadrus, Collinsella aerofaciens, Blautia wexlerae and Bifidobacterium longum strains that inhibit the activity of antibiotic-resistant bacteria.
INDUSTRY-ACADEMIC COOPERATION FOUNDATION (République de Corée)
EWHA UNIVERSITY - INDUSTRY (République de Corée)
Inventeur(s)
Lee, Kyuri
Lee, Hyuk Jin
Abrégé
The present invention relates to a nucleic acid construct that can express and inhibit a gene simultaneously. The nucleic acid construct that can express and inhibit a gene simultaneously, according to the present invention, comprises both mRNA and siRNA in a single construct, and thus, mRNA and siRNA are introduced simultaneously into the same cell. Accordingly, a protein to be expressed may be expressed normally while expression of a particular gene may be specifically inhibited. The mRNA-siRNA nucleic acid construct activates an immune system by expressing a target protein in an antigen-presenting cell, and at the same time, overcomes interference of immune escape by blocking the activity of an immune checkpoint protein, and thus is expected to be remarkably useful in the fields of immunotherapy, especially in the field of cancer immunotherapy.
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
CELLARTGEN INC. (République de Corée)
Inventeur(s)
Cho, Seung Woo
Lee, Mi Jeong
Song, Yong Seok
Hwang, Yong Soon
Abrégé
The present invention relates to nanoparticles comprising a decellularized spleen extracellular matrix and use thereof and, in particular, to: nanoparticles having a uniform size, which are obtained by producing hydrogel from a decellularized spleen extracellular matrix, and then freeze-milling the hydrogel; a method for producing same; use thereof; and the like. The nanoparticles comprising a decellularized spleen extracellular matrix, according to the present invention, have many excellent advantages such as an immunity-enhancing effect, biocompatibility, safety, biodegradability, and usability, and thus can be used as a novel adjuvant for enhancing vaccine immunity.
A61K 39/39 - Préparations médicinales contenant des antigènes ou des anticorps caractérisées par les additifs immunostimulants, p. ex. par les adjuvants chimiques
A61K 39/00 - Préparations médicinales contenant des antigènes ou des anticorps
84.
LACTOBACILLUS STRAINS, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME FOR PREVENTING OR TREATING INFLAMMATORY DISEASES
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Yoon, Mi Young
Abrégé
The present invention provides a pharmaceutical composition, an antibacterial composition, a probiotic composition, and a food additive composition, which are for treating or preventing inflammatory diseases, and contain, as an active ingredient, any one from among a Lactobacillus animalis strain and a Limosilactobacillus reuteri strain, which have an ability to adjust uric acid concentration, mixed strains (accession number: KCTC 15190BP) of the Lactobacillus animalis and Limosilactobacillus reuteri strains, a culture medium of the Lactobacillus animalis strain, a culture medium of the Limosilactobacillus reuteri strain, and a culture medium of the mixed strains (accession number: KCTC 15190BP).
Industry-academic Cooperation Foundation, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Cho, Hyung Hee
Lee, Nam Kyu
Lim, Joon Soo
Chang, In Joong
Bae, Hyung Mo
Nam, Ju Yeong
Abrégé
A multiple and broadband stealth structure comprises a radar absorption unit that absorbs broadband microwave, a low-frequency transmission filter unit that is stacked on an upper portion of the radar absorption unit, and an infrared radiation unit that is combined with the low-frequency transmission filter unit to selectively emit infrared ray, thereby selectively controlling the infrared emissivity of the surface to emit infrared radiation only through an atmospheric absorption window with a low infrared transmittance and to avoid the infrared detection system.
F41H 3/00 - Camouflage, c.-à-d. moyens ou procédés de dissimulation ou de simulation
B64D 7/00 - Agencement à bord aéronefs des équipements militaires, p. ex. des armes, des accessoires d'armement ou des blindages de protectionAdaptations des installations d'armement aux aéronefs
86.
HYDROGEL INCLUDING PHENOL DERIVATIVE-MODIFIED CELLULOSE AND USE THEREOF
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Cho, Seung Woo
Choi, Yi Sun
Jeon, Ji Hoon
Abrégé
A hydrogel including phenol derivative-modified cellulose, a use thereof, and a preparation method therefor are described. Physical properties of the hydrogel can be modulated by adjusting concentrations of and oxidation conditions for the phenol derivative-modified cellulose. In addition, the hydrogel of the present invention can find applications in various fields due to its properties, such as hemostasis, blood coagulation acceleration, tissue adhesion, cell culture, cell transplantation, drug delivery, etc.
SAMSUNG ELECTRONICS CO., LTD. (République de Corée)
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Lee, Ho Taik
Kim, Woochul
Kim, Jiyong
Kwon, Bok Soon
Kim, Sang Kyu
Kim, Sungho
Park, Gimin
Woo, Seungjai
Lee, So Young
Rhee, Hong Soon
Abrégé
A heat flux sensor according to an embodiment of the present disclosure includes: a thermogalvanic cell; a first electrode and a second electrode which are respectively disposed on a first surface and a second surface of the thermogalvanic cell; and a processor configured to estimate heat flux by measuring a voltage, generated by a temperature difference between the first surface and the second surface, by using the first electrode and the second electrode, wherein core body temperature may be estimated based on the heat flux, estimated by the heat flux sensor, and a skin surface temperature of an object.
G01K 13/20 - Thermomètres médicaux par contact pour les humains ou les animaux
G01K 7/02 - Mesure de la température basée sur l'utilisation d'éléments électriques ou magnétiques directement sensibles à la chaleur utilisant des éléments thermo-électriques, p. ex. des thermocouples
Industry-Academic Cooperation Foundation, Yonsei University (République de Corée)
Inventeur(s)
Lee, Yeong Hee
Kang, Ri Ra
Ryu, Kyoung Han
Lee, Byung Hong
Lee, Sang Il
Yun, In Sik
Park, Jang Ung
Abrégé
Disclosed are a transparent electrode for a solar cell and a method of manufacturing the same. The transparent electrode for a solar cell has a low Young's modulus, excellent elasticity, self-healing properties, an average visible-light transmittance sufficient to implement bifacial properties, and excellent power conversion efficiency (PCE). In addition, the method of manufacturing the transparent electrode for a solar cell does not require an additional deposition process, so the electrode-manufacturing time can be reduced, and the electrode-manufacturing process can be performed separately from other solar-cell-manufacturing processes, which is advantageous for mass production and large-area application.
H01G 9/00 - Condensateurs électrolytiques, redresseurs électrolytiques, détecteurs électrolytiques, dispositifs de commutation électrolytiques, dispositifs électrolytiques photosensibles ou sensibles à la températureProcédés pour leur fabrication
H01G 9/042 - Électrodes caractérisées par le matériau
89.
COLOR CHANGE SENSOR USING HOLLOW SILICA AND ION-PAIRING DYE CAPABLE OF DETECTING TRACE AMOUNTS OF ACETONE GAS
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Lee, Wooyoung
Kim, Jung Hyun
Shin, Kyusik
Park, Jae Jung
Kim, Youngno
Kim, Gaeun
Lee, Jihyun
Abrégé
The present disclosure relates to a color change dye prepared by impregnating hollow silica with a dye having a cationic dye and an anionic dye prepared using ion pairing, a sensor for detecting gas containing the above dye and a method for preparing the same, and more specifically to, a sensor that increases sensitivity and stability by increasing the area where the dye touches the gas and protecting the dye itself, since cationic dyes and anionic dyes are ion-paired to increase humidity resistance and react only with a trace amount of acetone. and the ion-paired dyes are then impregnated into hollow silica, and a method for preparing the same.
G01N 21/29 - CouleurPropriétés spectrales, c.-à-d. comparaison de l'effet du matériau sur la lumière pour plusieurs longueurs d'ondes ou plusieurs bandes de longueurs d'ondes différentes en utilisant la détection visuelle
G01N 33/00 - Recherche ou analyse des matériaux par des méthodes spécifiques non couvertes par les groupes
90.
MEMORY DEVICE USING A PLURALITY OF SUPPLY VOLTAGES AND OPERATING METHOD THEREOF
Samsung Electronics Co., Ltd. (République de Corée)
Industry-Academic Cooperation Foundation, Yonsei University (République de Corée)
Inventeur(s)
Choi, Taemin
Kim, Taehyun
Jung, Seongook
Abrégé
A memory device accessed by circuits operating based on a first supply voltage. The memory device includes a cell array electrically connected to a plurality of word lines and a plurality of bit lines; a row driver configured to select one word line of the plurality of word lines based on a row address; a precharge circuit configured to precharge the plurality of bit lines based on the first supply voltage; a column driver configured to select at least one bit line of the plurality of bit lines based on a column address; and a read circuit configured to read data stored in the cell array through the at least one bit line. The cell array, the row driver, the column driver, and the read circuit operate based on a second supply voltage, which is higher than the first supply voltage.
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Lee, Won Woo
Chu, Min Kyung
Abrégé
The present invention relates to a facial image-based method for providing information about a headache, and an apparatus using same, wherein the facial image-based method, which is implemented by a processor, comprises the steps of: receiving facial image data from a user device; determining landmark-identified facial image data with the facial image data as input, by using a landmark identification model configured to output the landmark-identified facial image data with the facial image data as input; and determining user headache data with the landmark-identified facial image data as input, by using a headache determination model configured to output the user headache data with the landmark-identified facial image data as input.
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
G16H 50/50 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour la simulation ou la modélisation des troubles médicaux
G16H 30/40 - TIC spécialement adaptées au maniement ou au traitement d’images médicales pour le traitement d’images médicales, p. ex. l’édition
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Cheong, Jae-Ho
Kim, Jae-Woo
Yoon, Bo Kyung
Abrégé
A composition and method according to the present invention may be very effectively used to diagnose malignant gastric cancer and predict the prognosis of gastric cancer.
C12Q 1/6886 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour les maladies provoquées par des altérations du matériel génétique pour le cancer
G01N 33/574 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour le cancer
93.
ANTENNA AND WEARABLE ELECTRONIC DEVICE INCLUDING SAME ANTENNA
Samsung Electronics Co., Ltd. (République de Corée)
INDUSTRY-ACADEMIC COOPERATION FOUNDATION YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Nam, Yongsik
Woo, Taehyun
Yoon, Youngjoong
Kim, Donghyun
Park, Chanyeong
Do, Myeounghyeoun
Han, Taegyeong
Abrégé
A wearable electronic device is provided. The wearable electronic device includes a housing, a printed circuit board disposed inside the housing and including wireless communication circuitry and a ground part, and an antenna disposed inside the housing and electrically connected to the wireless communication circuitry, wherein the antenna includes a conductive pattern, a feeding member electrically connected to the wireless communication circuitry through a feeding point and configured to electrically connect a first point of the conductive pattern and a first point of the ground part, a short-circuit member configured to electrically connect a second point of the conductive pattern and a second point of the ground part, and a capacitive loading member disposed between the feeding member and the short-circuit member having a first part operatively coupled to a third point of the conductive pattern and a second part electrically connected to a third point of the ground part.
THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY- ACADEMIC COOPERATION FOUNDATION (République de Corée)
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Joo, Young Hoon
Kim, Hyun Bum
Kim, Jong Baeg
Jung, Yo Han
Koh, Dae Yeon
Kim, Min Hyeong
Han, Hyun Jun
Abrégé
Proposed are a phlegm suction alarm issuing apparatus and a method for a tracheostomy patient which monitor and analyze a respiratory sound of the tracheostomy patient in real time, then check congestion of phlegm, and issue a phlegm suction alarm.
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/08 - Dispositifs de mesure pour examiner les organes respiratoires
95.
VEST-TYPE SPEAKER, SPEAKER CONTROL DEVICE, CONTROL METHOD, AND SYSTEM FOR REMOVING BRONCHIAL SPUTUM OF PATIENT WITH LUNG DISEASE BY USING VIBRATION AND SOUND WAVE
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Park, Incheol
Abrégé
This vest-type speaker device comprises: a communication unit; at least one speaker positioned corresponding to the user's lung; a memory; and a processor for controlling the operation of a battery, wherein the processor is configured to receive a control signal based on user condition information from an external electronic device through the communication unit, and output sound waves and vibrations through the at least one speaker on the basis of the control signal.
A61H 23/02 - Massage par percussion ou vibration, p. ex. en utilisant une vibration ultrasoniqueMassage par succion-vibrationMassage avec des membranes mobiles à entraînement électrique ou magnétique
A61M 16/00 - Dispositifs pour agir sur le système respiratoire des patients par un traitement au gaz, p. ex. ventilateursTubes trachéaux
H04R 1/32 - Dispositions pour obtenir la fréquence désirée ou les caractéristiques directionnelles pour obtenir la caractéristique directionnelle désirée uniquement
A61B 6/00 - Appareils ou dispositifs pour le diagnostic par radiationsAppareils ou dispositifs pour le diagnostic par radiations combinés avec un équipement de thérapie par radiations
A61B 5/055 - Détection, mesure ou enregistrement pour établir un diagnostic au moyen de courants électriques ou de champs magnétiquesMesure utilisant des micro-ondes ou des ondes radio faisant intervenir la résonance magnétique nucléaire [RMN] ou électronique [RME], p. ex. formation d'images par résonance magnétique
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Lim, Joonryul
Chun, Yong Min
Abrégé
The present invention relates to a forearm fixing apparatus for a therapeutic robot for restoring and maintaining the range of motion of joints of an upper extremity, comprising: a fixing unit in which the forearm of a user is fixed to one surface thereof; a handle that is provided to be inclined on one surface of the fixing unit and gripped by a hand of the user; a plurality of frames provided at intervals on the other surface of the fixing unit; and a connector that is detachably coupled to any one of the plurality of frames and provided on a robot arm.
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Cheong, Jae-Ho
Kim, Jae-Woo
Fang, Sungsoon
Yoon, Bo Kyung
Kim, Hyeonhui
Abrégé
The present invention relates to a method for prevention, alleviation, or treatment of cancer patients, especially epithelial mesenchymal transition (EMP)-subtype cancer patients. If PHGDH, SHMT and MTHFD2 inhibitors are co-administered to patients with cancer in which the expression level of a glutaminase (GLS) gene or a protein encoded thereby has increased, 1C metabolism is more effectively inhibited such that there is a synergistic effect on the inhibition of cancer cell proliferation in patients with refractory cancer that is difficult to treat because of recurrence, metastasis, and anticancer drug resistance, thereby enabling cancer to be very effectively treated. In addition, the expression level of the GLS gene or protein encoded thereby is measured so that information related to customized treatment methods from initial stages is provided to each patient and the success of treatment can be increased.
C12Q 1/6886 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour les maladies provoquées par des altérations du matériel génétique pour le cancer
98.
PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATORY DISEASES COMPRISING GERMANIUM TELLURIDE NANOSHEETS COATED WITH POLYVINYLPYRROLIDONE
Industry-Academic Cooperation Foundation (République de Corée)
Inventeur(s)
Yoo, Kyung-Hwa
Song, Jun Ho
Park, Yong-Beom
Lee, Sun-Mi
Min, Chin Hee
Yoon, Taejun
Abrégé
The present invention relates to a composition for treating inflammatory diseases comprising germanium telluride nanosheets coated with polyvinylpyrrolidone, and the nanosheets have excellent anti-inflammatory and thus are excellent in treating inflammatory bowel disease and psoriasis.
A61K 33/00 - Préparations médicinales contenant des ingrédients actifs inorganiques
A61K 33/04 - Soufre, sélénium ou tellureLeurs composés
A61P 1/04 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des ulcères, des gastrites ou des œsophagites par reflux, p. ex. antiacides, antisécrétoires, protecteurs de la muqueuse
A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]
A61P 37/00 - Médicaments pour le traitement des troubles immunologiques ou allergiques
99.
Gold-Doped Nickel Nanocluster, Preparation Method Therefor, and Use Thereof
Industry-Academic Cooperation Foundation, Yonsei University (République de Corée)
Inventeur(s)
Lee, Dongil
Choi, Woojun
Jo, Yongsung
Abrégé
Provided is a gold-doped nickel nanocluster having a specific number of gold atoms, nickel atoms, and organothiol-based ligands. The gold atoms, the nickel atoms, and the organothiol-based ligands are bonded in a specific structure, a method for manufacturing the same, an electrode for converting carbon dioxide including the same, and a method for converting carbon dioxide using the same.
C25B 11/095 - Électrodes comportant des électro-catalyseurs sur un substrat ou un support caractérisées par le matériau électro-catalytique formé d’au moins un élément catalytique et d’au moins un composé catalytiqueÉlectrodes comportant des électro-catalyseurs sur un substrat ou un support caractérisées par le matériau électro-catalytique formé de plusieurs éléments catalytiques ou composés catalytiques au moins un des composés est de type organique
AGENCY FOR DEFENSE DEVELOPMENT (République de Corée)
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (République de Corée)
Inventeur(s)
Kim, Jeong-Woo
Cho, Hyung-Hee
Lee, Joo-Hyoung
Bang, Min-Ho
Kim, Jeong-Ju
Choi, Seung-Yeong
Kim, Tae-Hyun
Park, Hee-Seung
Abrégé
The present invention relates to a gas turbine blade having a shelf squealer tip, the gas turbine blade including an airfoil-shaped blade housing, and a squealer tip extending from an edge portion of a tip surface that is an end surface of the blade housing, in which the squealer tip is formed only on a part of the edge portion of the tip surface. According to the present invention, it is possible to maximize film-cooling performance on the tip surface and additionally reduce an aerodynamic loss by suppressing high-temperature main flow reattachment and swirl flow generation on the tip surface.